Sec. 10.62.23.04. Contents of Certificate of Analysis

A. An independent testing laboratory shall issue to the licensed processor a certificate of analysis for each lot, with supporting data, to report:

(1) The concentrations of the following compounds:

(a) ∆9-Tetrahydrocannabinol (THC);

(b) Tetrahydrocannabinolic Acid (THCA);

(c) Cannabidiol (CBD);

(d) Cannabidiolic Acid (CBDA);

(e) The terpenes described in the most current version of the cannabis Inflorescence monograph published by the American Herbal Pharmacopeia (AHP);

(f) Cannabigerol (CBG); and

(g) Cannabinol (CBN); and

(2) That the presence of the following contaminants does not exceed the levels provided in the Commission’s current version of technical authority for medical cannabis testing:

(a) Any residual solvent or processing chemicals;

(b) Foreign material such as hair, insects, or any similar or related adulterant;

(c) Microbiological impurities such as:

(i) Total aerobic microbial count (TAMC);

(ii) Total yeast and mold count (TYMC);

(iii) Escherichia coli;

(iv) Salmonella spp.;

(v) Aflatoxin B1, B2, G1, and G2; and

(vi) Ochratoxin A.;

(d) Pesticide residue;

(e) Heavy metals; and

(f) Whether the batch is within specification for:

(i) Odor; and

(ii) Appearance.

B. Residual levels of volatile organic compounds (VOCs) shall be below the levels provided in the Commission’s current version of technical authority for medical cannabis testing.